Mylan and Pfizer Finalize Appointments to Viatris Board of Directors
February 28, 2020
February 28, 2020
NEW YORK, Feb. 28 -- Pfizer, a pharmaceutical company, issued the following news release on Feb. 27:
* * *
- 13 Inaugural Directors Bring Wide-Ranging Experience, Expertise and a Focus on Driving Shareholder Value
* * *
HERTFORDSHIRE, England, PITTSBURGH & Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) announced the remaining appointees to the inaugural 13-member Board of Directors for Viatris, the new company that will result from th . . .
* * *
- 13 Inaugural Directors Bring Wide-Ranging Experience, Expertise and a Focus on Driving Shareholder Value
* * *
HERTFORDSHIRE, England, PITTSBURGH & Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) announced the remaining appointees to the inaugural 13-member Board of Directors for Viatris, the new company that will result from th . . .